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Abstract –Zinc is an essential trace element involving in the activity of more than 300 enzymes and proteins of human body. One 
important role of zinc is to improve metallothionein protein binding heavy metals and functioning as heavy metal detoxification facilities. 
This research discusses the effect of zinc supplement  on the  improvement of metallothionein protein level. The in vivo test involving 28 
rats categorized in 4 groups was performed. The experiments used randomized post test control group design. The 3 groups were daily 
supplemented by zinc in th concentration of  0.2 mg, 0.4 mg, and 0.8 mg. Whereas, the last group was let without zinc treatment. As an 
indicator the metallothionein protein level was checked after three weeks. The data was then evaluated by Anova an Bonferroni test in 
order to know the signicant of protein level difference among the groups.  
The result showed that the average of metallothionein protein level improved by increasing zinc suppplement with the 0.95 ±0.20; 1.28 
±0.19; 1.39 ±0.09; 1.91 ±0.3 ng/ml metallothionein per 0, 0,2, 0,4, 0,8.mg zinc added. Based on the ANOVA and Bonferroni test, indicated 
that the improvement was significant as shown with p value  of 0.00 
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                                I. INTRODUCTION 
       Metallothionein was firstly discovered in 1957 as protein 
containing a large amount of sulphur and having a close 
relationship with zinc.  There was significant positive 
correlation between zinc and Metallothionein at any 
ages.(Blalock et al.,1988; Berdanier 1998; Lee et al,. 2013).            
       Metallothionein is a protein (polypeptide) having small 
molecular mass (4 – 8 kDa), containing cysteine amino acid 
(Cys), but having no aromatic amino acid or histidine. The 
classification of Metallothionein is based on the composition 
of amino acid, number and division of Cys-amino in 
sequence, and the similarity of phylogenic sequence and 
relationship. Metallothionein is not only found in any levels 
of tissues and organs but also in cytoplasm and nucleus 
(Steven et al.,2000) 
       The role of metallothionein in metal detoxification 
mechanism deals with the ability of metallothionein to bind 
toxic metals. Metallothionein is metal-binding protein 
functioning in the process of binding or locking up metals in 
tissues of every living thing. Thus, metallothionein can be 
used as indicator upon metal contamination. (Cheung  et al., 
2001; Jiang  et al ., 2013).  
       Metallothionein has the ability to bind metals strongly as 
it contains a large number of “thiol” groups (sulfidril, SH). 
The sulfide residue of Cys is able to bind metal ions of two or 
three SH residues. The binding coordination of each metal 
ion of Cys forms the structure of tetrahedral tetrathiolate. 
Cys residue is needed to detoxify heavy metal by binding the 
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transitional metal cations. (Cheung  et al., 2001; Jiang  et al ., 
2013).  
       The research conducted by Sulivan using ELISA method 
showed the relationship between zinc supplementation and 
metallothionein protein level. Zinc supplementation of 50 
mg/day to male adults improved the erythrocyte and 
monosyte metallothionein protein.( Sullivan et al., 1998).   
       Considerations upon the decision of zinc 
supplementation method procurement were the solubility, 
bioavailability, taste, side effect, and dosage frequency 
(Brown et al., 2002). An informal survey of zinc 
supplementation  showed that one of the basic 
considerations to use the zinc supplementation form was the 
taste. Zinc citrate taste with the dosage of 3 mg could not be 
accepted although in orange juice. Zinc sulphate and 
glutamate with the dosage of 10-20 mg was acceptable taste. 
(Allen 1998).   
       Zinc absorption or supplementation of food intake 
ranged from 15-60%. Zinc dosage between 5-20mg per day 
was mostly used in many researches for observing the 
influence of zinc to growth. Meta-analysis supplementation 
used the dosage of 1.5-50 mg per day with consideration to 
the number of materials inhibiting the absorption level. Zinc 
gradual supplementation dosage activity to improve 
metallothionein protein considers important aspects such as 
10 mg per day, 20 mg per day, and 40 mg per day. Those 
dosages have to be proportionally converted due to the 
animals used in experiment. For examples, the dosage of 10 
mg, 20 mg, and 40 mg were converted into 0.2, 0.4, and 0.8 
respectively (Donatus 1994).  Zinc supplementation with the 
appropriate dosage must be analyzed as the preventive 
effort to heavy metal toxicity.  
II. MATERIAL AND METHOD 
       This research used experimental method with 
Randomized post test only control-group design. The ethical 
clearance had been approved by the ethics commission of 
the medical faculty of Diponegoro University / Dr. Kariadi 
Hospital of Semarang No. 339/EC/FK/RSDK/2012 of 
October 18th, 2012. The samples taken from LPPT UGM were 
28 male rats called Rattus norvegicus,  with  15 weeks old, 
and  180-220 gram weight. Those 28 rats were divided into 
4 groups: 1 control and 3 treatment groups. Starting from 
the first to the third weeks, the treatment groups were 
gradually supplemented with 0.2 mg, 0.4 mg, and 0.8 mg of 
zinc per day, while the control group is not supplemented 
with zinc. At the end of third week, the metallothionein 
protein level in all groups was checked. The results were 
evaluated using one way Anova test followed by Bonferroni 
test in order to know the sginificant effect of the treatment.  
 
III. RESULTS AND DISCUSSION 
 
Metallothionein Level 
       Metallothionein levels of those control and treatment 
groups were checked in the third week. The average and 
trend of Metallothionein levels could be seen in table 1 and 
Fig. 1 below. 
 
Table 1. The Average of Metallothionein level of Control and 
Treatment Groups 
 
Group 
Metallothionein Level 
       Average (ng/ml)                    p 
KC 
KP1 
KP2 
KP3 
0.95  ±0.20 
1.28  ±0.19 
1.39  ±0.09 
1.91  ±0.32 
0.00 
 
 
           
Fig 1. Picture of Metallothionein level differences 
Group KC, KX1, KX2, KX3 
 
Table. 2. Bonferroni test upon Metallothionein level  
of Control and Treatment Groups 
Parameter Average 
Difference 
p  
MT KC with KP1 
MT KC with KP2 
MT KC with KP3 
0.32 
0.43 
0.95 
0.11 
0.16 
0.00 
 
Table 1 and Fig 1 showed that the unsupplemented rats of 
control group had the lowest Metallothionein level. 
Meanwhile the zinc-supplemented rats improved 
significantly. The higher dosage, the higher Metallothionein 
level. Here, wiith the  zinc supplementation of 0.8 mg (KX3), 
the Metallothionein level was 1.91 ng/ml(±0.32). The ANOVA 
test showed the value of p=0.00 and then followed by 
Bonferroni test (table 2) resulting in significant difference of 
control and zinc-supplemented treatment group of 0.8 mg 
(KX3) with the value of p=0.00. 
       Metallothionein level improved in accordance with zinc 
supplementation improvement. The zinc supplementation of 
0.2 mg, 0.4 mg, and 0.8 mg had the average of 
metallothionein of 1.28 ng/ml, 1.39 ng/ml, and 1.91 ng/ml 
respectively. These showed that the improvement of zinc 
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dosage supplementation is followed by the improvement of 
metallothionein protein level. 
       Supporting the research conducted by Sullivan et al. 
(1998) that zinc supplementation of 50 mg daily given to 
adult might improved erythrocyte and monocyte 
metallothionein protein. His research aimed to examine 
metallothionein gene transcription based on zinc index 
status to human after zinc supplementation. The method 
used enzyme linked immunoassay (ELISA) with sandwich 
approach. The monoclonal antibody was used to compare 
the level of erythrocyte metallothionein protein with the 
level of moncyte mRNA metallothionein. This aspect was 
measured using polymerase chain reaction (PCR) during zinc 
supplementation. 25 adult subjects of 19 to 35 years old 
were supplemented with zinc of 50 mg/day for 18 days 
while the control subjects were given placebo. The 
erythrocyte metallothionein protein level improved 
significantly in 8 days compared to the control subjects. The 
monocyte mRNA metallothionein protein level improved 
significantly in 2 days compared to control subjects. Zinc 
concentration plasma was significantly higher than control 
subjects in 6 days after zinc supplementation.   
       The research conducted by Aydemir TB et al, (2005) 
supported that zinc supplementation improved 
metallothionein protein. The research was conducted with 
male adult subjects of 19 to 31 years old. Zinc (ZnSO4) of 15 
mg/day was supplemented to treatment groups while 
placebo was given to control group. The metallothionein 
protein levels of the treatment groups improved better than 
the control one. 
       Metallothionein expression had promised as potential 
index of zinc status to animal and human. Blalock et al, 
(1988), Villalobos AR and Young RK, (2011) showed that 
mRNA expressions of livers, intestines, and kidneys were 
regulated by zinc intake. The metallothionein protein level in 
serum/plasma and erythrocyte of rats had been proven 
having good correlation with zinc intake. Zlotkin SH,(1988) 
stated that there was significant positive correlation 
between zinc and metallothionein at any ages. Gallant KR et 
al. (1987) said that metallothionein concentration of livers 
was directly regulated by zinc diet status, high concentration 
of high zinc diet, and low concentration of low zinc diet. 
ELISA Method could be used to know the concentration of 
metallothionein protein during zinc diet. This method was 
the initial effort to assess the zinc status based on the 
concentration of metallothionein protein during zinc 
supplementation.  
       This research showed that metallothionein protein 
concentration could be regulated by zinc supplementation. 
metallothionein is protein (polipeptida) having small 
molecular mass and containing  a great number of “thiol” 
groups as its main characteristic, 26-33% of cysteine amino 
acid (Cys), but having no aromatic amino acid or histidine     
(Cheung  et al., 2001; Zlotkin  et al., 2013).   
 
 
IV. CONCLUSION 
       The average of metallothionein level improved with the 
increase of zinc dosage supplementation. The highest 
methalothionein level of  1.91 ng/ml  was reached with 0.8 
zinc supplementation. Based on the statistical test, there was 
significant difference of metallothionein level between 
control and treatment group which was zinc-supplemented 
of 0.8 mg, with the value of p=0.00. 
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